European Journal of Gastroenterology and Hepatology This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.
Paper alert
No abstract available (Source: European Journal of Gastroenterology and Hepatology)
Source: European Journal of Gastroenterology and Hepatology - January 16, 2022 Category: Gastroenterology Tags: Paper Alert Source Type: research
Freezing of faeces dramatically decreases the viability of Blastocystis sp. and Dientamoeba fragilis
No abstract available (Source: European Journal of Gastroenterology and Hepatology)
Source: European Journal of Gastroenterology and Hepatology - January 16, 2022 Category: Gastroenterology Tags: Letters to the Editor Source Type: research
Hereditary angioedema and pancreatitis: two diseases that should remind each other
No abstract available (Source: European Journal of Gastroenterology and Hepatology)
Source: European Journal of Gastroenterology and Hepatology - January 16, 2022 Category: Gastroenterology Tags: Letters to the Editor Source Type: research
Assessment of proton-pump inhibitor use, race, socioeconomic status, and mortality in individuals with COVID-19
No abstract available (Source: European Journal of Gastroenterology and Hepatology)
Source: European Journal of Gastroenterology and Hepatology - January 16, 2022 Category: Gastroenterology Tags: Letters to the Editor Source Type: research
Liver injury could be associated with severe disease in COVID-19 patients: a meta-analysis
No abstract available (Source: European Journal of Gastroenterology and Hepatology)
Source: European Journal of Gastroenterology and Hepatology - January 16, 2022 Category: Gastroenterology Tags: Letters to the Editor Source Type: research
Hemosuccus pancreaticus: masquerader of variceal bleed in patient with alcoholic steatohepatitis
No abstract available (Source: European Journal of Gastroenterology and Hepatology)
Source: European Journal of Gastroenterology and Hepatology - January 16, 2022 Category: Gastroenterology Tags: Letters to the Editor Source Type: research
Survival and recurrence rates of hepatocellular carcinoma after treatment of chronic hepatitis C using direct acting antivirals
Background
Conflicting studies were proposed either suggested or denied the relationship between early hepatocellular carcinoma (HCC) recurrence and the use of direct-acting antivirals (DAAs) for chronic hepatitis C management
Aim of the study
To evaluate HCC recurrence rate post-DAAs and potential predictive factors.
Study This prospective cohort study included all HCC patients achieved complete response attending our multidisciplinary HCC clinic, Cairo University, from November 2013 to February 2018. Group I (60 patients) who received DAAs after HCC ablation and group II (273 patients) who were DAAs-untreat...
Source: European Journal of Gastroenterology and Hepatology - January 16, 2022 Category: Gastroenterology Tags: Original Articles: Hepatology Source Type: research
P53 is a risk factor of de-novo hepatitis C-related hepatocellular carcinoma treated with direct-acting antivirals: a case-control study
Background
The mechanisms underlying de-novo hepatocellular carcinoma (HCC) after direct-acting antivirals (DAAs) is still under investigation. This work aims to study P53 and hepatocyte growth factor (HGF) as possible diagnostics of de-novo hepatocellular carcinoma (HCC) following DAAs in comparison to alpha-fetoprotein (AFP).
Method
This case-control study included 166 patients with liver cirrhosis divided into group-1: patients without HCC (n = 50), group-2: patients with de-novo HCC following DAAs, and achieved sustained virological response (n = 50), and group-3: patients with HCC without DAAs (n ...
Source: European Journal of Gastroenterology and Hepatology - January 16, 2022 Category: Gastroenterology Tags: Original Articles: Hepatology Source Type: research
Combining immune checkpoint inhibitor with lenvatinib prolongs survival than lenvatinib alone in sorafenib-experienced hepatocellular carcinoma patients
Conclusion
The ALBI grade and sorafenib treatment history were predictors for OS in HCC patients receiving lenvatinib. For sorafenib-experienced patients, combining ICI with lenvatinib achieved better OS than lenvatinib alone. (Source: European Journal of Gastroenterology and Hepatology)
Source: European Journal of Gastroenterology and Hepatology - January 16, 2022 Category: Gastroenterology Tags: Original Articles: Hepatology Source Type: research
Safety and efficacy of outpatient continuous terlipressin infusion for the treatment of portal hypertensive complications in cirrhosis
Conclusion
Transplant-eligible and otherwise stable patients can be managed with CTI at home for an extended duration under supervision without adverse consequences. (Source: European Journal of Gastroenterology and Hepatology)
Source: European Journal of Gastroenterology and Hepatology - January 16, 2022 Category: Gastroenterology Tags: Original Articles: Hepatology Source Type: research
A prospective cohort study of the use of the fatty liver index and Fibroscan to determine the prevalence of fatty liver disease in an Irish population
Objectives
Rates of nonalcoholic fatty liver disease (NAFLD) are increasing worldwide. The fatty liver index (FLI) is a noninvasive predictor of NAFLD. This prospective cohort study used the FLI to estimate the prevalence of NAFLD in patients attending an Irish Acute Medical Unit (AMU), and assessed the degree of fibrosis in this group using Fibroscan.
Methods
Patients attending the AMU over a 3-month period were invited to participate. Patients with excess alcohol consumption or pre-existing liver disease were excluded. Using established FLI cut-offs, 414 participants were grouped into low (FLI ≤ 30), medium ...
Source: European Journal of Gastroenterology and Hepatology - January 16, 2022 Category: Gastroenterology Tags: Original Articles: Hepatology Source Type: research
Procedural bleeding risk, rather than conventional coagulation tests, predicts procedure related bleeding in cirrhosis
Background
Standard coagulation parameters are used to guide prophylactic blood product transfusion prior to invasive procedures in cirrhotic patients despite limited high-quality evidence.
Aims
We aimed to describe coagulation parameters and prophylactic blood product use in cirrhotic patients having invasive procedures, and the influence of both on periprocedural bleeding.
Methods
We conducted a cohort study of cirrhotic patients undergoing invasive procedures at a referral hospital. Procedures were classified into low or moderate-high bleeding risk. Prophylactic blood component was defined as fresh fro...
Source: European Journal of Gastroenterology and Hepatology - January 16, 2022 Category: Gastroenterology Tags: Original Articles: Hepatology Source Type: research
Rebleeding after hemoclip versus argon plasma coagulation for gastrointestinal angiodysplasias: a retrospective multicenter study
Conclusion
Treatment modality was not a significant predictor of rebleeding when studied for the entire population. However, the risk of rebleeding was lower with hemoclips combination therapy compared to APC in patients that resumed antithrombotic therapy, suggesting a potential role for a combined approach in this subgroup of patients. (Source: European Journal of Gastroenterology and Hepatology)
Source: European Journal of Gastroenterology and Hepatology - January 16, 2022 Category: Gastroenterology Tags: Original Articles: Gastroenterology Source Type: research
Impact of endoscopist experience, patient age and comorbidities on dose of sedation and sedation-related complications by endoscopic ultrasound
Conclusion
Endosonographer experience, patient age and the presence of comorbidities had a significant influence on sedation dose. Sedation-related complications occurred only in 1.8% of cases. (Source: European Journal of Gastroenterology and Hepatology)
Source: European Journal of Gastroenterology and Hepatology - January 16, 2022 Category: Gastroenterology Tags: Original Articles: Gastroenterology Source Type: research
Gastrointestinal symptoms are associated with severity of coronavirus disease 2019: a systematic review and meta-analysis
Conclusion
The severe rate was more than 40% in COVID-19 patients with gastrointestinal symptoms. Abdominal pain was associated with a near 2.8-fold increased risk of severe COVID-19; the relationship between diarrhea and the severity of COVID-19 was regionally different; nausea and vomiting were limited in association with an increased risk of severe COVID-19. (Source: European Journal of Gastroenterology and Hepatology)
Source: European Journal of Gastroenterology and Hepatology - January 16, 2022 Category: Gastroenterology Tags: Original Articles: Gastroenterology Source Type: research